Midostaurin: Nursing Perspectives on Managing Treatment and Adverse Events in Patients With FLT3 Mutation–Positive Acute Myeloid Leukemia and Advanced Systemic Mastocytosis | ONS
POLICY & PROCEDURE UM ONC_1315
Midostaurin: Nursing Perspectives on Managing Treatment and Adverse Events in Patients With FLT3 Mutation–Positive Acute Myeloid Leukemia and Advanced Systemic Mastocytosis | ONS
Midostaurin for the treatment of acute myeloid leukemia | Future Oncology
Rydapt: Package Insert / Prescribing Information - Drugs.com
PDF) Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia | Bone Marrow Transplantation
PHARMACY POLICY STATEMENT
Comparison of the Kinase Profile of Midostaurin (Rydapt) with That of Its Predominant Metabolites and the Potential Relevance of Some Newly Identified Targets to Leukemia Therapy | Biochemistry
207997Orig1s000 207997Orig2s000
Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia... | Oncotarget
Rydapt, INN-midostaurin
Midostaurin Soft Gelatin INFLITZA 25MG CAPSULES, Intas Pharmaceuticals, 1X10 at Rs 2952/strip in New Delhi
Comparison of the Kinase Profile of Midostaurin (Rydapt) with That of Its Predominant Metabolites and the Potential Relevance of Some Newly Identified Targets to Leukemia Therapy | Biochemistry